Last reviewed · How we verify
dalfampridine ER
dalfampridine ER is a Small molecule drug developed by Brown, Theodore R., M.D., MPH. It is currently FDA-approved. Also known as: Ampyra serial number 77948545.
Dalfampridine ER is a small molecule medication used to treat conditions such as post-ischemic stroke and multiple sclerosis, as indicated by ClinicalTrials.gov. It is available in two dose strengths, 7.5mg and 10mg, and is administered orally in extended release tablet form.
At a glance
| Generic name | dalfampridine ER |
|---|---|
| Also known as | Ampyra serial number 77948545 |
| Sponsor | Brown, Theodore R., M.D., MPH |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- 4AP for Carpal Tunnel Syndrome (CTS) (PHASE2)
- Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients (PHASE2, PHASE3)
- Dalfampridine in Egyptian Patients With Multiple Sclerosis (NA)
- Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. (PHASE3)
- A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis (PHASE4)
- A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. (PHASE3)
- Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (PHASE2)
- A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dalfampridine ER CI brief — competitive landscape report
- dalfampridine ER updates RSS · CI watch RSS
- Brown, Theodore R., M.D., MPH portfolio CI
Frequently asked questions about dalfampridine ER
What is dalfampridine ER?
Who makes dalfampridine ER?
Is dalfampridine ER also known as anything else?
What development phase is dalfampridine ER in?
Related
- Manufacturer: Brown, Theodore R., M.D., MPH — full pipeline
- Also known as: Ampyra serial number 77948545
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing